Purchase Order 75F40125P00095
Award Date 6/18/25
Potential Completion Date 10/16/25
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a $248,000 firm fixed price purchase order to Emulate Inc. for Emulate Chip-S1 Basic Research Kits on September 19, 2025. The contract, with an ultimate completion date of September 18, 2026, will be performed at the FDA's Silver Spring, Maryland location. No set-aside designation was applied to this procurement. Emulate Inc., headquartered in Boston, Massachusetts, is a biotechnology company specializing in organ-on-chip microphysiological systems that...
- Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip technology, was awarded a $145,260 firm fixed-price purchase order by the Food and Drug Administration on August 1, 2024. The contract calls for delivery of the CHIP-S1 Stretchable Chip (catalog number 10231-2) with an ultimate completion date of August 31, 2024. This award was designated as a Total Small Business set-aside, recognizing Emulate's status as a small business entity. The Food and Drug Administration, a...
- The Food and Drug Administration awarded a purchase order to Emulate Inc. for $45,000 on August 28, 2025, for the procurement of organ-on-chip culture modules, specifically two Emulate Zoe CM1 units and one Orb Hub Module-1. The contract is structured as a firm fixed-price purchase order with an ultimate completion date of August 28, 2026, and performance will take place at the FDA's facility in Silver Spring, Maryland. No set-aside designation was used for this award. Emulate Inc., a...
- The Food and Drug Administration (FDA) awarded a $48,680.00 firm fixed price purchase order to Emulate Inc., a for-profit small business, for the purchase of Emulate Chip-S1 Basic Research Kits. This contract supports the FDA's regulatory science initiatives and advances the agency's work on non-animal testing approaches. The award has an ultimate completion date of August 21, 2025. Emulate Inc. has previously received federal grants, including a cooperative agreement from the Defense Advanced...
- The Department of Health and Human Services' Food and Drug Administration awarded a $104,500 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the procurement of five liver human emulation system 24 pack quad liver chip kits. The place of performance will be Emulate's facilities in Boston, Massachusetts. The period of performance is one year, from June 27, 2023 through June 26, 2024. This contract has a total small business set aside designation. The liver chip kits...
- The Department of Health and Human Services Food and Drug Administration awarded a $149,130 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the delivery of a CDER-2023-117371-ZOE MODULE (ZOE-CM2) WITH AN ORB HUB (ORB-HM1) MCMI23 - ROBUST ORGAN-ON-A-CHIP SYSTEM FOR BIOASSAY DEVELOPMENT. This award responds to Solicitation 75F40123Q00376 which sought a robust organ-on-a-chip system to support the FDA's bioassay development work. Place of performance will be...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order contract to Emulate Inc., a for-profit small business, with a potential value of $218,100.00. The contract is for the delivery of two (2) each of the Human Emulation System ZOE Culture Module 2 and two (2) each of the Orb Hub Module. Emulate's organ-on-a-chip technology is designed to model human biology and supports federal initiatives in areas like personalized medicine,...
- The Department of the Army Materiel Command Research Development and Engineering Command has awarded a $127,850.00 firm-fixed-price purchase order to Emulate Inc., a for-profit organization, to provide emulate organ-on-a-chip systems and associated products. This award is not associated with a set-aside program. Emulate's organ-on-a-chip technology is designed to model human biology for biomedical research, supporting federal initiatives in areas like personalized medicine, biosurveillance,...
- This is a $142,686.37 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Emulate Inc. (doing business as Emulate), a for-profit small business. The contract is for Emulate's human emulation organ-on-a-chip instruments and accessories, which support the National Institute of Neurological Disorders and Stroke's mission to develop in vitro 3D brain organoid models for studying neurological...
- This is a federal purchase order contract awarded by the Department of Veterans Affairs (VA) to Emulate Inc., a biotechnology company specializing in organ-on-chip technology. The $75,000.00 firm fixed-price contract is for the delivery of Life Cell Analyzers, which are part of Emulate's advanced microphysiological systems that replicate human organ functions. The contract does not have a set-aside designation. Emulate, based in Boston, Massachusetts, has supplied a variety of organ-on-chip...